Libéralisation et accès des pays pauvres à la santé Quelle responsabilité des droits de propriété intellectuelle et des firmes ?

Bruno Boidin ()

Mondes en développement, 2002, vol. 120, issue 4, 63-74

Abstract: Are intellectual property rights and pharmaceuticals companies really guilty for the problem of access to medicines in poor countries ? A review of the literature shows that the issue is complex and must take account of the different causes and actors involved in the access to health care. We then examine how firms seem to be more and more involved in the ?new? international strategies for the health improvement. From this we conclude on the necessity to clarify the objectives of the firms when building partnerships with poor countries.

Date: 2002
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=MED_120_0063 (application/pdf)
http://www.cairn.info/revue-mondes-en-developpement-2002-4-page-63.htm (text/html)
free

Related works:
Working Paper: Libéralisation et accès des pays pauvres à la santé: quelle responsabilité des droits de propriété intellectuelle et des firmes ? (2002)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:meddbu:med_120_0063

Access Statistics for this article

More articles in Mondes en développement from De Boeck Université
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().